240 likes | 433 Vues
simsivnesTan asocirebuli serologiuri markerebi. Tbilisi 2014. კლინიკო-დიაგნოსტიკური ლაბორატორია. laboratoria amkvidrebs profesiuli saqmianobis umaRles standartebs da moqmedebs mxolod pacientis interesebis Sesabamisad . aRWurvilia uaxlesi mRalteqnologiuri diagnostikuri aparaturiT
E N D
simsivnesTanasocirebuliserologiurimarkerebi Tbilisi 2014
კლინიკო-დიაგნოსტიკური ლაბორატორია • laboratoriaamkvidrebsprofesiulisaqmianobisumaRlesstandartebs da moqmedebsmxolodpacientisinteresebisSesabamisad. • aRWurviliauaxlesimRalteqnologiuridiagnostikuriaparaturiT • laboratoriaSimuSaobenmaRalikvalifikaciisspecialistebi, maTSorismecnierebaTaakademuridoqtorebi • laboratoriaSisruldebasxvadasxva tipis uzustesihematologiuri, koagulaciuri, bioqimiuri, imunologiurikvlevebi
laboratoriaSixorcieldebaSemdegiimunologiurigamokvlevebi: • farisebrijirkvlishormonebi: T3, T4, FT3, FT4, TSH, Anti-TG, Anti-TPO • sasqesohormonebi: PRL, E2, LH, FSH, TESTO, FTESTO, PROG, 17-OH-PROG, DHEA-S • onko-markerebi: CEA, CA-125, CA-15-3, CA-19-9, PSA, FPSA, AFP, HCG, BAP, SCC, S100, HE4, ROMA • infeqciuridaavadebebi: HBsAg, HCV, HIV • HSV IgG/IgM; CMV IgG/IgM; TOXO IgG/IgM; Chlam Tr. IgG/IgM • sxvadasxva: Insulin, C-Peptide, Cortisolda a.S.
gardaimisa, rom laboratoriaSiyoveldRiuradxorcieldebaSidalaboratoriulixarisxiskontroli, igiCarTuliagarexarisxiskontrolissaerTaSorisoprogramaSi – RIQAS (External Quality Assessment (EQA) Program) Randox, UK, romlisaxalicikliiwyeba 2013 wlisianvridanlaboratoriagaerTianebulia 3 programaSi:Monthly Immunology programmeMonthly Coagulation programme Monthly Clinical Chemistry programmelaboratoriaregistrirebuliakompaniissaitze, yovelTviuradigzavnebaSedegebiinternetiT da ramdenimedReSimiviRebTstatistikuraddamuSavebulSedegebs.
simsivnesTanasocirebuliserologiurimarkerebi markerebi – nivTierebebia, romelTakoncentraciamatulobssxvadasxvabiologiursiTxeebSi (sisxli, Sardi, kistisSigTavsi, asciturisiTxe da a.S.) onkologiuridaavadebebismqonepacientebSi.
simsivnesTanasocirebuliserologiurimarkerebi om-s diagnostikuriRirebulebaganisazRvrebamaTispecifiurobiTa da mgrZnobelobiT. • mgrZnobeloba – onkologiurpacientebSirealuraddadebiTiSedegissixSire, gamosaxuliprocentSi. • specifiuroba – janmrTel da keaTilTvisebianidaavadebebismqoneadamianebSirealuraduaryofiTiSedegissixSire, gamosaxuliprocentSi. • om iTvlebaidealurad, Tumisispecifiuroba da mgrZnobelobaSeadgenas 100%.
klasifikacia • lokalizaciismixedviT - specifiuroba da informatiuloba • biologiuri – qimiuristruqtura, ujredulifunqcia, embriogenezi • simsivnesTanasocirebuliglikoproteinebi (CA-125, CA-19-9, CA-15-3, CA-72-4, CA-242 da a.S.) • fermentebi(PSA, NSE) • citokinebi (IL-6, IL-10, EGF (epidermalurizrdisfaqtori) • mwvavefaziscilebi(feritini, CRP)
serologiurionkomarkeriCA-125 • CA-125 - maRalmolekulurimucinisglikoproteinuriepitopia, romelicmiekuTvnebaonkofetaluricilebisklass • normisfarglebijanmrTeliqalebisaTvis: < 35 U/ml • mismomatebasganapirobebsavTvisebianiaxalwarmonaqmnebi: sakvercxis, sarZevejirkvlis, endometriozissimsivne, filtvisadenokarcinoma, kuWqveSajirkvlis, hepatocelularulisimsivne, metastaziRviZlSi. • serozuli tipis sakvercxissimsivnisdrosCA-125-isdiagnostikuri mgrZnobelobavarirebs 42% -dan (I-II stadia) 99%-mde (IV stadia) • CA-125-is mgrZnobelobasisxlSisakvercxisserozuli tipis kibosrecidivisdrosaRemateba 90%-s.
serologiurionkomarkeriHE4 • HE4 miekuTvnebaproteinazebis inhibitors • mJavaglikoproteiniaoTxidisupfiduribmiT da 25 kdaltonimasiT • HE4 eqspresirdebareproduqtiuliorganoebis, zedasasunTqigzebis da kuWqveSajirkvlisnormalurepiTelSi. cilismomatebuliwarmoqmnaZiriTadadgamovleniliasakvercxisa da endometriumissimsivnis, iSviaTadfiltvisadenokarcinomisgavrcelebuliformisdros. • kvlevebmaaCvenes, rom orimarkerisHE4 da CA-125 erToblivigansazRvramniSvnelovnadzrdismaTdiagnostikurRirebulebassakvercxissimsivnisaRmoCenisadreulstadiaze da mciremenjisavTvisebiani da keTilTvisebianiwarmonaqmnebisdiferencialurdiagnostikaSi.
serologiurionkomarkeriHE4 • HE4 da CA-125 –is kombinirebuligansazRvramniSvnelovnadzustadgansazRvravsavTvisebianiwarmonaqmnisarsebobas, vidrenebismierisxvamarkericalkeaRebuli an romelimesxvamarkerTankombinaciaSi • mecnierebismierSemuSavebuliasakvercxisavTvisebianisimsivnisganviTarebisgansazRvrisalgoriTmi – Risk of Ovarian Malignancy Algorithm – ROMA – post- da premenopauzismqoneqalebSisakvercxisepiTelurisimsivnisganviTarebisriskisSesafaseblad. • algoriTmiiTvaliswinebsHE4 da CA-125 –is koncentraciisgansazRvrassisxlSi, asevepacientismenopauzisstatuss. is saSualebasiZlevagaiTvalossakvercxisepiTelurisimsivnisaRmoCenisalbaToba.
sakvercxissimsivne sakvercxissimsivnisdReisaTvisSedarebiTSeswavliliserologiuri om
individualuri da kombinirebulisimsivnurimarkerebismgrZnobeloba 90%-ianispecifiurobisdros
siaxle! pirveladsaqarTveloSiTbilisisonkologiuridispanserislaboratoriaSisruldebasakvercxisavTvisebianobisriskisalgoriTmis (ROMA) gamoTvla • ROMA – Risk of Ovarian Malignancy Algorithm – gamoiyeneba pre- da postnopauzismqoneqalebSisakvercxisepiTelurisim-sivnisganviTarebisriskisSesafaseblad • algoriTmisaSualebasiZlevaganisazRvrossakvercxisepiTelurisimsivnisavTvise-bianobisxarisxi • kvlevasruldebakompania “Fujirebio Diagnostics, Inc” (Sweden) – warmoebuliumaRlesixarisxis test-sistemebiT • TiToeulpacientsutardebaorikvleva: CA-125 da HE4 • miRebuliSedegebimuSavdebaspecialuriprogramissaSualebiT • algoriTmiiTvaliswinebsCA-125 daHE4-is koncentraciassisxlSi, asevepacientismeno-pauzisstatuss • premenopauza: dabaliriski <13 maRaliriski >13 • postmenopauza: dabaliriski <28 maRaliriski >28
markerebiskvleva da masalisaReba • om-s SemcvelobassisxlSigansazRvravenradioimunuri, imunofermentuli da qemiluminescentulimeTodebiT. • zustiSedegebismisaRebadZaliandidimniSvnelobaaqvssakvlevimasalissworadaRebas da Senaxvas. • ZiriTadisakvlevimasalaaSrati, romelicmiiRebauzmodaRebulivenurisisxlidan. hemolizurinimuSebissaanalizodgamoyenebaaraarekomendirebuli.
sisxlisSegrovebasaanalizod SearCieTsisxlisasaRebiadgili moamzadeTyvelasaWironivTi da gaikeTeTxelTaTmani daawereTsinjaraspacientissaidentifikacionomeri (TuaseTiarsebobs) an saxeli da gvari moargeTpacientsJguti
sisxlisSegrovebasaanalizod daamuSaveTspirtiTsisxlisaRebisadgili daafiqsireTkani da dabalkuTxianidaxriTSeiyvaneTnemsivenaSi aiReTsisxlisinjaraSie.w.Clot Activator (SratismisaRebad) JgutiundamoixsnasrogorckisisxlisnakadiwamovasinjaraSi gamoiReTnemsivenidan da daaWireTpunqciisadgilas SeamowmeTpunqciisadgilidaakariTleikoplastiri gamoyenebulinemsigadaagdeT
sisxlisSegrovebasaanalizod aRebulisisxlinazadgadaatrialeT 5-6-jer sisxlis da SededebisaqtivatorisSerevisaTvis moixseniTxelTaTmanebi da daibaneTxelebi sinjarebimoaTavseTStativSivertikalurpoziciaSi da daayovneToTaxistemperaturaze minimum 30wT
sisxlisSegrovebasaanalizod SratisgamosayofadsinjarebidaacentrifugeT 10 wT 1300g oTaxistemperaturispirobebSi. TuarmoxdaSratissruladgamoyofa, saWiroakidevdamatebiTdacentrifugeba6-8wT analizisaTvisSratiundagadataniliqnaspasterispipetiT an avtomaturipipetiT 1.5-2ml-ian ependorfSi da SevinaxoTmacivarSi (4-8C). SeniSvna: yovelinimuSisaTvisundagamoviyenoTaxalipipeti an pipetiswveri
sisxlisSegrovebasaanalizod • transportireba: • yvelanimuSimisiaRebisa da momzadebisSemdegundagadavagzavnoTTbilisisonkologiuridispanserislaboratoriaSi. • yvelasinjs Tan undaaxldesSesabamisiganacxadi, sadacaRniSnuliiqnebamasalisaRebisTariRi, pacientissaxeli, gvari, asaki da menopauzisstatusi. asevemasalisgamogzavnisTariRi. M • masala transportirdebasamedicinosinjebistransportirebisaTvisgankuTvnilispecialuriTermoCanTebiT (2-8C) • TiToeulisinjimowmdeba da dadasturdebalaboratoriaSimiRebisTanave. saTanadoidentifikaciisarmqonepirveladisinjebilaboratoriismierarmiiReba da SesabamisadardamuSavdeba!
Sedegad, andeTTqvenijanmrTelobapacientis da misukanmdgomiojaxiswinaSeudidesipasuxismgeblobismqoneprofesionalebs!